Compare Cronos Group Inc (CRON) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Schwab US Dividend Equity ETF — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Schwab US Dividend Equity ETF trades at $33.04 (market cap $110.56B). The key difference: Schwab US Dividend Equity ETF is far larger — about 93.7× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 23,539,168). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Schwab US Dividend Equity ETF for 62 Days on average.
| CRON | SCHD | |
|---|---|---|
Market Cap | $1.18B | $110.56B |
Volume | 968,037 | 23,539,168 |
Sector | Health | Broad Market / Factor |
52-Week High | $3.55 | $35.21 |
52-Week Low | $2.30 | $26.44 |
Typical Hold Time | 22 Days | 62 Days |
Enterprise Value | $387.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $146.59M in 2025, but net income was -$9.45M. Recent Q2 2026 earnings beat expectations with EPS of $0.09. The company held its first Investor Day in September 2026, highlighting international expansion and cash flow focus.
Outlook is mixed: strong revenue growth and a solid balance sheet with no debt support upside, but profitability remains inconsistent. Risks include cash flow volatility and competitive pressures. Analyst consensus is cautious with 60% hold ratings, reflecting uncertainty amid expansion efforts.
SCHD trades at $33.06, up 1.26% today, with a bullish technical signal despite mixed moving averages. The ETF has outperformed the S&P 500 in 2026, with recent news highlighting its dividend growth and defensive positioning. Key support sits at $32 with resistance at $34, while oscillators show neutral momentum. The fund's rules-based approach focuses on high-quality dividend stocks, though recent exclusions like Broadcom have sparked discussion about opportunity costs.
SCHD offers income investors exposure to rising dividends with lower fees, but faces headwinds from interest rate sensitivity and strict selection criteria that may limit growth participation. The current pullback from August highs near $35 presents a potential entry point for dividend-focused portfolios seeking quality and yield sustainability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
